Skip to the guide
tesamorelin
injections

Questions behind the belly-fat shot

Questions to take

Welcome desk · A guide to finding care

Tesamorelin injections, without the sales pitch.

Trying to work out what this is, or whether an offer adds up? Start here. This handbook helps you understand and find care; it does not provide prescriptions.

A real medicine. A specific purpose.

In September 2026, tesamorelin (EGRIFTA SV, EGRIFTA WR) had approval from FDA (Food and Drug Administration) for adults with HIV-related lipodystrophy.

Its approved purpose is to reduce excess fat in the belly.

HIV is short for human immunodeficiency virus.

Lipodystrophy is a change in where the body holds fat.

That gap matters when you compare an offer with what you hope to change. Ask the prescriber to name the goal in plain words.

Open the source drawer

Start with the offer in front of you.

US law puts tesamorelin in a medicine group with separate approval rules (September 2026).

FDA says federal law forbids pharmacies from preparing their own versions of medicines in this group (September 2026).

Compounding creates medicine for a particular order instead of dispensing the finished drug.

A lower quote does not answer the product question. Write down the exact medicine name before comparing costs.

Find care and check the medicine
Open the source drawer

Find the desk that matches your question.

A blank notebook, blue glass paperweight, and pale green ceramic cup on a tidy desk.
A place to pause, read, and put your questions in order.